Literature DB >> 30252577

Knee extensor and flexor strength before and after anterior cruciate ligament reconstruction in a large sample of patients: influence of graft type.

Raphael Huber1, Claudio Viecelli1, Mario Bizzini1, Bernd Friesenbichler1, Markus Dohm-Acker1, Thomas Rosenheck1, Laurent Harder1, Nicola A Maffiuletti1.   

Abstract

OBJECTIVE: Hamstring and patellar tendon autografts are the most frequently-used graft types for anterior cruciate ligament (ACL) reconstruction, with no consensus on their respective effects on thigh muscle strength. The objective of this study was to re-examine isokinetic knee extensor and flexor strength before and after ACL reconstruction with patellar and hamstring tendon grafts using a single-center and a relatively large database, where surgical, rehabilitation and testing procedures were strictly standardized for all patients.
METHODS: A total of 464 patients with a unilateral ACL rupture underwent arthroscopic ACL reconstruction with either patellar or hamstring tendon grafts. Isokinetic concentric strength was evaluated prior to surgery and at 5- and 9-month postoperative follow-ups in different patient subgroups (n = 140, 464 and 215, respectively).
RESULTS: Knee extensor strength was lower in patients operated with the patellar tendon graft at the 5-month (p < 0.05) but not at the 9-month follow-up. Knee flexor strength was lower in patients operated with the hamstring tendon graft at both postoperative time points (p < 0.05). The prevalence of quadriceps weakness was high (66-91%) in both patient groups at both follow-ups.
CONCLUSION: Overall, postoperative recovery of thigh muscle function seems to be better with the patellar than with the hamstring tendon graft due to the fact that both, knee extensor and flexor strength, were more impaired after ACL reconstruction with the hamstring tendon autograft.

Entities:  

Keywords:  Muscle strength; anterior cruciate ligament; autograft; hamstring; quadriceps

Mesh:

Year:  2018        PMID: 30252577     DOI: 10.1080/00913847.2018.1526627

Source DB:  PubMed          Journal:  Phys Sportsmed        ISSN: 0091-3847            Impact factor:   2.241


  7 in total

Review 1.  Recommendations for Hamstring Function Recovery After ACL Reconstruction.

Authors:  Matthew Buckthorpe; Furio Danelon; Giovanni La Rosa; Gianni Nanni; Matthew Stride; Francesco Della Villa
Journal:  Sports Med       Date:  2020-12-17       Impact factor: 11.136

2.  Patellofemoral contact forces after ACL reconstruction: A longitudinal study.

Authors:  Jack R Williams; Kelsey Neal; Abdulmajeed Alfayyadh; Ashutosh Khandha; Kurt Manal; Lynn Snyder-Mackler; Thomas S Buchanan
Journal:  J Biomech       Date:  2022-02-10       Impact factor: 2.712

3.  Hamstring-to-Quadriceps Ratio in Female Athletes with a Previous Hamstring Injury, Anterior Cruciate Ligament Reconstruction, and Controls.

Authors:  Eleftherios Kellis; Nikiforos Galanis; Nikolaos Kofotolis
Journal:  Sports (Basel)       Date:  2019-09-28

Review 4.  Quadriceps Strength After Anterior Cruciate Ligament Reconstruction Compared With Uninjured Matched Controls: A Systematic Review and Meta-analysis.

Authors:  Conlan Brown; Lee Marinko; Michael P LaValley; Deepak Kumar
Journal:  Orthop J Sports Med       Date:  2021-04-08

5.  Patellar Tendon Orientation and Strain Are Predictors of ACL Strain In Vivo During a Single-Leg Jump.

Authors:  Zoë A Englander; Brian C Lau; Jocelyn R Wittstein; Adam P Goode; Louis E DeFrate
Journal:  Orthop J Sports Med       Date:  2021-03-18

Review 6.  Limited evidence for graft selection in pediatric ACL reconstruction: a narrative review.

Authors:  Gianni De Petrillo; Thierry Pauyo; Corinna C Franklin; Ross S Chafetz; Marie-Lyne Nault; Louis-Nicolas Veilleux
Journal:  J Exp Orthop       Date:  2022-01-14

7.  Home-Based Nonoperative-Side Quadriceps Neuromuscular Electrical Stimulation Prevents Muscle Weakness Following Anterior Cruciate Ligament Reconstruction.

Authors:  Vanessa Wellauer; Julia F Item; Mario Bizzini; Nicola A Maffiuletti
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.